How to dispel myths in the treatment of hepatic encephalopathy?

Comment

Alain Braillon. Nat Clin Pract Gastroenterol Hepatol. 2007 Oct.

. 2007 Oct;4(10):E1; author reply E2.

doi: 10.1038/ncpgasthep0958.

No abstract available

Comment on

Preoperative evaluation of patients with liver disease.
Hanje AJ, Patel T. Hanje AJ, et al. Nat Clin Pract Gastroenterol Hepatol. 2007 May;4(5):266-76. doi: 10.1038/ncpgasthep0794. Nat Clin Pract Gastroenterol Hepatol. 2007. PMID: 17476209 Review.

Lactulose treatment for hepatic encephalopathy, gastrointestinal symptoms, and health-related quality of life.
Kalaitzakis E, Björnsson E. Kalaitzakis E, et al. Hepatology. 2007 Sep;46(3):949-50; author reply 951. doi: 10.1002/hep.21760. Hepatology. 2007. PMID: 17879365 No abstract available.
Lactulose a day keeps encephalopathy at bay.
Klinken E, MacQuillan G. Klinken E, et al. J Gastroenterol Hepatol. 2011 Jun;26(6):939-40. doi: 10.1111/j.1440-1746.2011.06742.x. J Gastroenterol Hepatol. 2011. PMID: 21564285 No abstract available.
[Intestine specific broad spectrum antibiotic. Rifaximin: therapy option in hepatic encephalopathy].
[No authors listed] [No authors listed] MMW Fortschr Med. 2014 Feb 20;156(3):64-5. MMW Fortschr Med. 2014. PMID: 24938070 German. No abstract available.
Long-term management of hepatic encephalopathy with lactulose and/or rifaximin: a review of the evidence.
Hudson M, Schuchmann M. Hudson M, et al. Eur J Gastroenterol Hepatol. 2019 Apr;31(4):434-450. doi: 10.1097/MEG.0000000000001311. Eur J Gastroenterol Hepatol. 2019. PMID: 30444745 Free PMC article. Review.
Lactulose Management of Minimal Hepatic Encephalopathy: A Systematic Review.
Zucker DM, Redulla R. Zucker DM, et al. Gastroenterol Nurs. 2019 Jan/Feb;42(1):84-94. doi: 10.1097/SGA.0000000000000429. Gastroenterol Nurs. 2019. PMID: 30688711